NU Lin
Impact in
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.1%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Cancer Research 117
- Breast Cancer Treatment Studies 99
- Cancer Genomics and Diagnostics 26
- Oncology 118
- HER2/EGFR in Cancer Research 64
- Cancer Immunotherapy and Biomarkers 15
- Cancer survivorship and care 12
- Co-authors
- Eric P. Winer (106 shared papers)Ana Christina Garrido-Castro (12 shared papers)Kornélia Polyák (3 shared papers)Jennifer Ruth Bellon (8 shared papers)Lalitha Krishna Shankar (5 shared papers)Elisabeth de Vries (6 shared papers)Janet Ellen Dancey (5 shared papers)Frank Stephen Hodi (5 shared papers)
- Journals
- Journal of Clinical Oncology (38 papers)Breast Cancer Research and Treatment (33 papers)Clinical Cancer Research (23 papers)Annals of Oncology (22 papers)Neuro-Oncology (19 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
NU Lin
360 papers receiving 32.9k citations
NU Lin's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 7k
- Oncology 9.1k
- Pulmonary and Respiratory Medicine 12.4k
- Genetics 921
- Radiology, Nuclear Medicine and Imaging 1.7k
Countries citing papers authored by NU Lin
This map shows the geographic impact of NU Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by NU Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites NU Lin more than expected).
Fields of papers citing papers by NU Lin
This network shows the impact of papers produced by NU Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by NU Lin. The network helps show where NU Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside NU Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 381 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics Hit paper breakdown → | 2017 | 1901 |
| 2 | RECIST 1.1—Update and clarification: From the RECIST committee Hit paper breakdown → | 2016 | 1503 |
| 3 | Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases Hit paper breakdown → | 2011 | 1198 |
| 4 | Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment Hit paper breakdown → | 2019 | 1097 |
| 5 | 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) Hit paper breakdown → | 2020 | 1029 |
| 6 | Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Hit paper breakdown → | 2019 | 992 |
| 7 | Response assessment criteria for brain metastases: proposal from the RANO group Hit paper breakdown → | 2015 | 873 |
| 8 | Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets Hit paper breakdown → | 2015 | 858 |
| 9 | Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors Hit paper breakdown → | 2017 | 758 |
| 10 | 2008 | 620 | |
| 11 | Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study Hit paper breakdown → | 2017 | 609 |
| 12 | CNS Metastases in Breast Cancer Hit paper breakdown → | 2004 | 591 |
| 13 | 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer Hit paper breakdown → | 2021 | 587 |
| 14 | Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer Hit paper breakdown → | 2009 | 555 |
| 15 | 2012 | 536 | |
| 16 | Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer Hit paper breakdown → | 2016 | 442 |
| 17 | Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial Hit paper breakdown → | 2020 | 438 |
| 18 | Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Hit paper breakdown → | 2008 | 392 |
| 19 | TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes Hit paper breakdown → | 2020 | 372 |
| 20 | Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement Hit paper breakdown → | 2017 | 369 |
About NU Lin
NU Lin is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Genetics, having authored 381 papers that have together received 33.6k indexed citations. Recurring topics across this work include Brain Metastases and Treatment (116 papers), Breast Cancer Treatment Studies (99 papers), HER2/EGFR in Cancer Research (64 papers), Advanced Breast Cancer Therapies (27 papers), Cancer Genomics and Diagnostics (26 papers), Cancer Immunotherapy and Biomarkers (15 papers), Cancer survivorship and care (12 papers) and Ethics in Clinical Research (11 papers). The work is most often cited by research in Cancer Research (7k citations), Oncology (9.1k citations), Pulmonary and Respiratory Medicine (12.4k citations), Genetics (921 citations) and Radiology, Nuclear Medicine and Imaging (1.7k citations). NU Lin has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Eric P. Winer, Ana Christina Garrido-Castro, Kornélia Polyák, Jennifer Ruth Bellon, Lalitha Krishna Shankar, Elisabeth de Vries, Janet Ellen Dancey, Frank Stephen Hodi, Patrick Therasse and Saskia Litière. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Clinical Cancer Research, Annals of Oncology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.